Related stories
PTC Therapeutics Board Approves Up to $500 Million Stock Buyback
The company's board approved plans to repurchase up to $500 million of its common stock.
L impact | EQUITY | Nov 03, 2026, 07:04 PM UTC
Q&R Signs Bond Loan Agreement for Up to EUR 7.9 Million
Q&R signed a bond loan agreement with Alpha Bank for up to EUR 7.9 million.
M impact | EQUITY | Nov 03, 2026, 07:04 PM UTC
Analysts Lower BioMarin Price Targets After Q3 Earnings
Oppenheimer cut its target to $94 from $97, RBC to $60 from $62, and Wedbush to $89 from $94. All three firms maintained their existing ratings.
M impact | EQUITY | Nov 03, 2026, 07:03 PM UTC
CHSN: trading halted on Nasdaq — volatility pause (2:01 PM ET)
Nasdaq halted trading in CHSN (volatility pause) at 2:01 PM ET.
L impact | EQUITY | Nov 03, 2026, 07:01 PM UTC
US session market picture: S&P 500 +0.52%, Nasdaq 100 +0.89%; EUR/USD +0.06%, WTI -0.5%, WBD leads volume
US session market picture. US index futures: S and P futures is up 0.52 percent, Nasdaq futures is up 0.89 percent, Dow futures is down 0.3 percent and Russell futures is up 0.65 p
M impact | EQUITY | Nov 03, 2026, 07:00 PM UTC
Teamsters Local 282 Authorizes Strike at US Foods
M impact | EQUITY | Nov 03, 2026, 06:56 PM UTC